The European Pharmaceutical Preparations sector exhibits notable variations in Gross Value Added per Employee FTE among countries. In 2023, Belgium led the group with the highest performance at 829.3 thousand euros, whereas Romania was at the lower end with 49.5 thousand euros. Countries like Switzerland and Germany also demonstrated robustness, though significantly lower than Belgium. The annual growth over recent years has been minimal across the board, indicating a relative stability in this metric. The Compound Annual Growth Rate (CAGR) suggests steady, albeit modest, improvements over a five-year period.
Future trends to watch include:
- Technological advancements that could enhance productivity and efficiency.
- Regulatory changes impacting market dynamics.
- Cross-border collaboration and investment in R&D.
- Potential impact of geopolitical factors on supply chains.
Top countries in Pharmaceutical Preparations Gross Value Added Per Employee FTE by Country
| # | 10 Countries | Thousand Euros | Last Year | |
|---|---|---|---|---|
| 1 | 1 Belgium | 829.3 | 2023 | View data |
| 2 | 2 Switzerland | 515.4 | 2023 | View data |
| 3 | 3 Germany | 213.1 | 2023 | View data |
| 4 | 4 Netherlands | 189.5 | 2023 | View data |
| 5 | 5 Italy | 187.5 | 2023 | View data |
| 6 | 6 Iceland | 142.6 | 2023 | View data |
| 7 | 7 Austria | 141.2 | 2023 | View data |
| 8 | 8 Spain | 109.6 | 2023 | View data |
| 9 | 9 Hungary | 81.8 | 2023 | View data |
| 10 | 10 Czech Republic | 78.7 | 2023 | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
